Clinical Trial

IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This trial aims to implement and compare an evidence- and theory-based intervention strategy (IGNITE-TX Intervention) to support probands and their ARRs in family communication, informed decision-making, and navigation to CGT with standard of care, free genetic testing/counseling, and intervention with free genetic testing/counseling.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-29.
Trial Details
NCT Number NCT07318363
Lead Sponsor M.D. Anderson Cancer Center
Conditions Communication, Informed Decision-making
Enrollment 2,100 participants
Start Date 2026-12-01
Primary Completion 2030-04-01 (estimated)
Study Completion 2032-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-17